Efficiency of Different Exercise Approaches in Individuals Providing Primary Care to MS
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05896995 |
Recruitment Status :
Completed
First Posted : June 9, 2023
Last Update Posted : July 19, 2023
|
Sponsor:
Istanbul Medipol University Hospital
Information provided by (Responsible Party):
hazal genc, Istanbul Medipol University Hospital
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | June 1, 2023 | ||||
First Posted Date ICMJE | June 9, 2023 | ||||
Last Update Posted Date | July 19, 2023 | ||||
Actual Study Start Date ICMJE | May 1, 2023 | ||||
Actual Primary Completion Date | June 15, 2023 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
|
||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Efficiency of Different Exercise Approaches in Individuals Providing Primary Care to MS | ||||
Official Title ICMJE | Investigation of the Efficiency of Different Exercise Approaches in Individuals Providing Primary Care to Multiple Sclerosis Patients | ||||
Brief Summary | Multiple Sclerosis is known as an inflammatory central nervous system disease characterized by demyelination and axonal damage. | ||||
Detailed Description | Individuals with MS cannot perform self-care in many areas due to the problems they encounter during their daily life activities, and they need an individual who will take care of them and a lifelong care. | ||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Investigator) Primary Purpose: Treatment |
||||
Condition ICMJE | Back Pain | ||||
Intervention ICMJE |
|
||||
Study Arms ICMJE |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Completed | ||||
Actual Enrollment ICMJE |
41 | ||||
Original Estimated Enrollment ICMJE |
42 | ||||
Actual Study Completion Date ICMJE | July 7, 2023 | ||||
Actual Primary Completion Date | June 15, 2023 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 18 Years to 65 Years (Adult, Older Adult) | ||||
Accepts Healthy Volunteers ICMJE | No | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | Turkey | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT05896995 | ||||
Other Study ID Numbers ICMJE | 2023-07/02 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE |
|
||||
Current Responsible Party | hazal genc, Istanbul Medipol University Hospital | ||||
Original Responsible Party | Same as current | ||||
Current Study Sponsor ICMJE | Istanbul Medipol University Hospital | ||||
Original Study Sponsor ICMJE | Same as current | ||||
Collaborators ICMJE | Not Provided | ||||
Investigators ICMJE | Not Provided | ||||
PRS Account | Istanbul Medipol University Hospital | ||||
Verification Date | July 2023 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |